Acute/subacutae demyelinating polyneuropathy in Parkinson's Disease patients on levodopa-carbidopa intestinal gel therapy: systematic review with new case report.

Polyneuropathy (PNP) is a known complication of levodopa-carbidopa intestinal gel (LCIG) therapy of advanced Parkinson's Disease (PD). The overall prevalence of PNP in PD is estimated to be 42.1% (as shown in a review by Romagnolo et al.

Neuroimaging in Parkinson's Disease: necessity or exaggeration?

Introduction: Neuroimaging plays an increasingly important role in the diagnosis of parkinsonian syndromes.

Aim Of The Study: In this paper, the authors elaborate on the necessity of using magnetic resonance imaging (MRI) in Parkinson's Disease (PD) and its potential role in differential diagnosis versus other neurodegenerative parkinsonian syndromes such as dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy and corticobasal syndrome.

State Of The Art: The currently known characteristic abnormalities are listed and tabulated, current recommendations are summarised and sample images are provided.